👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr Timothy Sevitt
Oncology
English
10,120+
Patients seen
2
Years in practice
3
Publications
1
Languages spoken
About
Dr Timothy Sevitt trained at the prestigious Cambridge University and Addenbrookes Hospital Medical School, qualifying in 1998.
Dr Sevitt completed his general medical training in Ipswich and Bury St Edmunds, after which he moved to London to work at the Royal Marsden Hospital. His decision to then train in Clinical Oncology led to him passing his Fellowship in the Royal College of Radiologists in 2005. During his training, he also gained a fellowship to work at the Peter MacCallum Cancer Centre in Melbourne, Australia; a recognition of his excellence and skill in his field.
Dr Sevitt completed his oncology training in 2008 and was appointed as a Consultant Clinical Oncologist at the Kent Oncology Centre. He specialises in the management of Lung and Upper GI carcinomas and has developed stereotactic radiotherapy (SABR) and IMRT treatments for lung and upper GI malignancies in Kent, treating patients with high rates of success.
Dr Sevitt has previously been chair of the West Kent Lung Multidisciplinary team for the 4 years and the NIHR Sub-speciality lead for lung cancer in Kent, Surrey and Sussex. In addition to this, Dr Sevitt also has a keen interest in both research and education and is a Training Program Director for Clinical Oncology; helping to train the next generation of oncologists.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Radiotherapy
• Stereotactic Ablative Radiotherapy (SABR)
• Video Consultation
• Intensity Modulated Radiotherapy (IMRT)
• Gastro-Intestinal Cancers
• Lung Cancer
• Oesophageal Cancer
Dr Sevitt completed his general medical training in Ipswich and Bury St Edmunds, after which he moved to London to work at the Royal Marsden Hospital. His decision to then train in Clinical Oncology led to him passing his Fellowship in the Royal College of Radiologists in 2005. During his training, he also gained a fellowship to work at the Peter MacCallum Cancer Centre in Melbourne, Australia; a recognition of his excellence and skill in his field.
Dr Sevitt completed his oncology training in 2008 and was appointed as a Consultant Clinical Oncologist at the Kent Oncology Centre. He specialises in the management of Lung and Upper GI carcinomas and has developed stereotactic radiotherapy (SABR) and IMRT treatments for lung and upper GI malignancies in Kent, treating patients with high rates of success.
Dr Sevitt has previously been chair of the West Kent Lung Multidisciplinary team for the 4 years and the NIHR Sub-speciality lead for lung cancer in Kent, Surrey and Sussex. In addition to this, Dr Sevitt also has a keen interest in both research and education and is a Training Program Director for Clinical Oncology; helping to train the next generation of oncologists.
Diseases, Medical Tests and Treatments
• Chemotherapy
• Radiotherapy
• Stereotactic Ablative Radiotherapy (SABR)
• Video Consultation
• Intensity Modulated Radiotherapy (IMRT)
• Gastro-Intestinal Cancers
• Lung Cancer
• Oesophageal Cancer
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr Timothy Sevitt
Education & training
-
2016–2022 MD · Medicine and Surgery
-
2022–2026 Residency · Oncology
Career & appointments
-
2026-09–2027-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 3,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,910 |
| Annual physical exam | 99395 | 1,960 |
| Vaccination administration | 90471 | 2,944 |
| Minor procedure (skin) | 17110 | 719 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 90 min | in_clinic | 360.00 EUR |
| Minor procedure (skin) | 60 min | in_clinic | 270.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 8 · i10: 9
-
Long-term follow-up of Oncology across GB
DOI: 10.6963/euroclin.2026.0 · PMID: 37789636 · cited by 166
-
Validation of clinical scoring in Oncology
DOI: 10.4332/euroclin.2025.1 · PMID: 37354184 · cited by 76
-
Long-term follow-up of Oncology across GB
DOI: 10.4224/euroclin.2024.2 · PMID: 35168722 · cited by 58
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2027
- national college of family doctors — Member · since 2027
- European Union of Medical Specialists (UEMS) — Member · since 2027
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.timothy.sevitt@euroclinics.example
